[1] 汪远金,许金林,张杰等.大豆异黄酮对卵巢大鼠骨质疏松的实验研究[J].食品科学,2003,24(2):120-122.[2] 蔡标,申国明,汪远金等.大豆异黄酮对AD大鼠海马Apo-E4的影响[J]. 辽宁中医药大学学报,2011, 13(7):117-119.[3] 蔡标,彭代银,汪远金等.大豆异黄酮对AD大鼠海马NO-cGMP信号转导系统的影响[J]. 中国中药杂志, 2011, 36(2):29-32.[4] 李仪奎.中药药理实验方法学[M]第二版.上海:上海科技出版社,2006:293-294.[5] 王维治.神经病学[M].北京:人民卫生出版社,2008:1397-1400.[6] Weldon DT, Rogers SD, Ghilardi JR,et al. Fibrillar beta-amy-loid induces microglial phagocytosis, expression of induciblenitric oxide synthase, and loss of a select population of neu-rons in the rat CNS in vivo[J]. J Neurosci, 1998,18:2161-2173.[7] Danson TM, Gonzalez-zulueta M, Kusel J. Nitric oxide: diverse actions in the central and peripheral nervous systems[J]. Neuroscientist, 1998,4:96-142.[8] Khan TK, Alkon DL. An internally controlled peripheral biomarker for Alzheimer’s desease:ERK1 and ERK2 responses to the inflammatory signal bradykinin[J]. Proc Natl Acad Sci U S A,2006,29,103(35):13203-13207.[9] Delgado M, Varela N, Gonzalez-Rey E. Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels[J]. Glia, 2008,1,56(10):1091-103. [10]Tong L, Balazs R, Soiampornkul R, et al. Transforming growth factor-beta 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase[J]. Mol Pharmacol, 2007,72(6):1476-83.[11]Haskell SG, Richardson ED, Horwitz RI, et al. The effect of estrogen replacement therapy on cognitive function in women:a critical review of the literature[J]. J Clin Epidemiol, 1997, 50(11): 1249-1264.[12]Morinaga A, Hirohata M, Ono K, et al. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro[J]. Biochem Biophys Res Commun(S0006-291X), 2007, 359(3):697-702.[13]Greenfield JP, Leung LW, Cai D.Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans -Golgi network vesicle biogenesis[J]. J Biol Chem, 2002,277(14):12128 -12136.[14]吕海燕,贾建平.雌激素治疗阿尔茨海默病的争议[J].中国临床康复,2005,9(13):125-127.[15]Reiter E, Beck V, Medjakovic S, et a1. Isoflavones are safe compounds for therapeutical applications-Evaluation of in vitro data[J]. Gynecol Endocrinol, 2009, 7(7): 1-27. |